Company Analysis
Sign in

CareDx, Inc. (CDNA)

Nasdaq: CDNA · Services-Medical Laboratories · Brisbane, CA · filing with the SEC since 2003
Full chart Alerts Compare
Grade5.2
◀ Past 4.9● Present 5.2▶ Future 5.6
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

32 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to CareDx, Inc.’s names, not what it holds today.

Patents granted
32
32 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against none in 2024 and 1 in 2023
Applications published
46
7 of them in 2025
Names they are printed under
6
a former name, its own name, a subsidiary
By yearGrantedApplications published
'02'03'04'05'06'07'09'10'11'12'16'21'22'23'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology2
Digital communication1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
Xdx, Inc. a former name
US, as the owner printed on each patent
25 granted
18 published
CareDx, Inc. its own name
named as the applicant on its applications, in US
0 granted
20 published
Expression Diagnostics, Inc. a former name
US, as the owner printed on each patent
4 granted
5 published
CareDx, Inc. its own name
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in AU)
2 granted
2 published
CAREDX TRANSPLANT MANAGEMENT, INC. a subsidiary
US, as the owner printed on each patent
1 granted
0 published
CareDx Transplant Management, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 2, 202512,404,547Methods and systems for monitoring a recipient of an allograftBiotechnologyCareDx, Inc.
Mar 25, 202512,256,728Systems and methods for vital asset transportDigital communicationCAREDX TRANSPLANT MANAGEMENT, INC.
Sep 26, 202311,767,559Methods of monitoring immunosuppressive therapies in a transplant recipientBiotechnologyCareDx, Inc.
Apr 3, 20128,148,067Methods for diagnosing and monitoring the status of systemic lupus erythematosusBiotechnologyXdx, Inc.
Feb 7, 20128,110,364Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseasesPharmaceuticalsXdx, Inc.
Aug 9, 20117,993,832Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disordersAnalysis of biological materialsXdx, Inc.
Jun 14, 20117,960,121Methods and compositions for diagnosing and monitoring transplant rejectionBiotechnologyXdx, Inc.
Feb 22, 20117,892,745Methods and compositions for diagnosing and monitoring transplant rejectionBiotechnologyXdx, Inc.
Feb 1, 20117,879,556Methods and compositions for diagnosing and monitoring transplant rejectionBiotechnologyXdx, Inc.
Nov 9, 20107,829,286Methods and compositions for diagnosing and monitoring transplant rejectionBiotechnologyXdx, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0388965METHODS AND SYSTEMS FOR PROCESSING CELL-FREE SAMPLESBiotechnologyCareDx, Inc.
Nov 20, 20252025/0354207METHODS AND SYSTEMS FOR MONITORING A RECIPIENT OF AN ALLOGRAFTBiotechnologyCareDx, Inc.
Oct 16, 20252025/0322906SYSTEMS AND METHODS FOR DISTINGUISHING NUCLEIC ACIDS IN MIXED SAMPLESComputer technologyCareDx, Inc.
Oct 9, 20252025/0316333SEQUENCE-BASED ANALYSIS OF NUCLEIC ACIDS IN MIXED SAMPLESComputer technologyCareDx, Inc.
Jun 26, 20252025/0210203APPARATUSES, COMPUTER-IMPLEMENTED METHODS, AND SYSTEMS FOR GENERATING AND DYNAMICALLY UPDATING A METRIC PROGRESS AGGREGATION INSIGHT INTERFACE IN ASSOCIATION WITH A PRE- OR POST-TRANSPLANT RECIPIENTMedical technologyCareDx, Inc.
Jun 12, 20252025/0185645SYSTEMS AND METHODS FOR VITAL ASSET TRANSPORTDigital communicationCareDx Transplant Management, Inc.
Jan 9, 20252025/0011871METHODS FOR NON-INVASIVELY MONITORING ORGAN HEALTH IN CROSS-SPECIES TRANSPLANTATIONBiotechnologyCareDx, Inc.
Dec 21, 20232023/0407396METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTBiotechnologyCareDx, Inc.
Dec 21, 20232023/0407395METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTBiotechnologyCareDx, Inc.
Dec 21, 20232023/0407394METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTBiotechnologyCareDx, Inc.
What it applied for, 2024 to 2025: Biotechnology 3 · Computer technology 2 · Digital communication 1 · Medical technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton CDNA · research, not advice